Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)
Public ClinicalTrials.gov record NCT00862134. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase II, Multi-Center, Open-Label Trial of PR104 and Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT00862134
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Proacta, Incorporated
- Industry
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- Granulocyte colony-stimulating factor Drug
- PR104 Drug
- docetaxel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2009
- Primary completion
- Dec 31, 2009
- Completion
- Apr 30, 2010
- Last update posted
- Jan 9, 2013
2009 – 2010
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sharp Clinical Oncology Research | San Diego | California | 92123 | — |
| University of Miami/Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Orchard Research, LLC | Skokie | Illinois | 60076 | — |
| Midwestern Regional Medical Center | Zion | Illinois | 60099 | — |
| St. Francis Health Services | Beech Grove | Indiana | 46107 | — |
| McFarland Clinic/William R. Bliss Cancer Center | Ames | Iowa | 50010 | — |
| Iowa Blood & Cancer Care | Cedar Rapids | Iowa | 52402 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Montgomery Cancer Center | Mount Sterling | Kentucky | 40353 | — |
| Baton Rouge General/Penington | Baton Rouge | Louisiana | 70809 | — |
| Annapolis Oncology Center | Annapolis | Maryland | 21401 | — |
| Lapidus Cancer Center/Sinai Hospital | Baltimore | Maryland | 21215 | — |
| Kalamazoo Hematology & Oncology | Kalamazoo | Michigan | 49048 | — |
| VA Sierra Nevada Health Care System | Reno | Nevada | 89502 | — |
| VA Medical Center | Durham | North Carolina | — | — |
| Piedmont Hematology Oncology Associates, PLLC | Winston-Salem | North Carolina | 27103 | — |
| Cincinnati VA Medical Center | Cincinnati | Ohio | 45220 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | — | — |
| WJB Dorn VA Medical Center | Columbia | South Carolina | 29209 | — |
| ACORN | Memphis | Tennessee | 38120 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75246 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| Texas Oncology - Allison Cancer Center | Midland | Texas | 79701 | — |
| Scott & White Memorial Hospital | Temple | Texas | 76508 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00862134, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 9, 2013 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00862134 live on ClinicalTrials.gov.